Drug Information

Drug General Information
Drug ID
D0F3IP
Former ID
DAP001457
Drug Name
Asasantin
Drug Type
Small molecular drug
Indication Cerebrovascular ischaemia [ICD9: 434.91; ICD10:I61-I63] Approved [536186]
Company
Boehringer Ingelheim Corp
Structure
Download
2D MOL

3D MOL
Formula
C33H48N8O8
Canonical SMILES
CC(=O)OC1=CC=CC=C1C(=O)O.C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C<br />3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
InChI
1S/C24H40N8O4.C9H8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30;1-6(10)13-8-5-3-2-4-7(8)9(11)12/h33-36H,1-18H2;2-5H,1H3,(H,11,12)
InChIKey
NOHUXXDTQJPXSB-UHFFFAOYSA-N
CAS Number
CAS 87653-67-6
PubChem Compound ID
137329
PubChem Substance ID
14888442, 29314645, 50065538, 57345534, 80733060, 104389637, 126438543, 134224867, 134338656, 135095332, 226776016
Target and Pathway
Target(s) Cyclooxygenase Target Info Inhibitor [536186]
References
Ref 536186Emerging drugs in peripheral arterial disease. Expert Opin Emerg Drugs. 2006 Mar;11(1):75-90.
Ref 536186Emerging drugs in peripheral arterial disease. Expert Opin Emerg Drugs. 2006 Mar;11(1):75-90.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.